Long-term survival in malignant intracranial germ-cell tumors: a report of two cases and a review of the literature.
The authors report the successful treatment of two cases of malignant germ-cell tumor. A 12-year-old patient with a pineal immature teratoma and increase of alpha-fetoprotein serum levels was treated with total excision and cisplatin, vinblastine, and bleomycin (PVB) in combination given twice. One year later, he had a recurrence of tumor in the right occipital lobe, which was totally removed, and yolk sac tumor was verified. As subsequent adjuvant chemotherapy, PVB was given in four courses over 1.5 years, together with one course of cisplatin-etoposide (PE) therapy. The patient is well 5 years and 9 months after the first operation. In the second case, a 19-year-old patient with a pineal mixed germ-cell tumor, composed of germinoma, yolk sac tumor, and embryonal carcinoma, was treated with total excision, followed by four courses of PVB therapy and one of PE. She has done well in the 4.5 years since the initial treatment. Thus, aggressive extirpation of the lesion and subsequent combination chemotherapy using cisplatin and other multiple drugs, given in at least four courses over 1.5 years, even if tumor markers return to within normal limits, might provide successful treatment for malignant germ-cell tumors.
Sakai
N
N
Department of Neurosurgery, Gifu University School of Medicine, Japan.
Yamada
H
H
Andoh
T
T
Nishimura
Y
Y
Niikawa
S
S
D000328:Adult; D001932:Brain Neoplasms / Q000401:mortality*; D002648:Child; D018240:Endodermal Sinus Tumor / Q000401:mortality; D005260:Female; D018237:Germinoma / Q000401:mortality*; D006801:Humans; D008297:Male; D010870:Pineal Gland; D015996:Survival Rate; D013724:Teratoma / Q000401:mortality